ADAMIS PHARMACEUTICALS CORP

SAN DIEGO, CA How do I update this listing?

Create Email Alert

Adamis Pharmaceuticals Corp is based out of San Diego. Adamis Pharmaceuticals Corporation, formerly Cellegy Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged in the development and commercialization of prescription drugs targeting primarily women's health care, including the reduction in transmitting of human immunodeficiency virus (HIV), female sexual dysfunction and gastrointestinal conditions using topical formulations and nitric oxide donor technologies. The Company's wholly owned subsidiary includes Biosyn, Inc. (Biosyn).Whalewisdom has at least 103 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2022-07-07. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Contact Info

adamis pharmaceuticals corp
11682 EL CAMINO REAL
SAN DIEGO CA    92130

Business Phone: (858) 997-2400
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2022-07-07 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 300,000 300,000 0
2020-06-30 D PHARMACEUTICALS Equity,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 590,000 590,000 0
2020-03-06 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 6,090,000 6,090,000 0
2013-07-11 D PHARMACEUTICALS Debt,Option, Warrant or Other Right to Acquire Another Security,Other 6,502,158 6,502,158 0
2013-04-24 D PHARMACEUTICALS Debt,Other 575,000 575,000 0
2012-07-09 D PHARMACEUTICALS Debt,Other 1,000,000 1,000,000 0
2012-04-06 D PHARMACEUTICALS Equity,Debt,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 3,299,920 3,299,920 0
2010-11-23 D PHARMACEUTICALS Equity 5,000,000 0 5,000,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
DENNIS J. CARLOS subscription required
    EXECUTIVE OFFICER DIRECTOR
DAVID J. MARGUGLIO subscription required
    EXECUTIVE OFFICER DIRECTOR
ROBERT O. HOPKINS subscription required
    EXECUTIVE OFFICER DIRECTOR
RICHARD L. ALOI subscription required
    EXECUTIVE OFFICER DIRECTOR
DENNIS J. CARLO subscription required
    EXECUTIVE OFFICER DIRECTOR
KENNETH M. COHEN subscription required
    DIRECTOR
CRAIG S. JOHNSON subscription required
    DIRECTOR
TINA S. NOVA, PH.D subscription required
    DIRECTOR
KAREN K. DANIELS subscription required
    EXECUTIVE OFFICER
TINA S NOVA, PH. D. subscription required
    EXECUTIVE OFFICER
THOMAS MOLL subscription required
    EXECUTIVE OFFICER
RICHARD C WILLIAMS subscription required
    DIRECTOR
HOWARD C BIRNDORF subscription required
    DIRECTOR
ROSHAWN BLUNT subscription required
    DIRECTOR
RONALD B MOSS subscription required
    EXECUTIVE OFFICER
MEERA J. DESAI subscription required
    DIRECTOR
VICKIE S. REED subscription required
    DIRECTOR
DAVID C. BENEDICTO subscription required
    EXECUTIVE OFFICER

Elevate your investments